MYCN and neuroblastoma: One such example is shown in the study of Fonseka et al., 2019 [33]; these authors discovered that exosomes released from neuroblastoma cells overexpressing N-Myc promoted cell survival and chemoresistance in recipient cells that did not possess amplified N-Myc, and thus prevented cell apoptosis induced by doxorubicin and promoted cancer progression.